IL-1 Gene Screening Identifies Coronary Artery Disease Susceptibility
This article was originally published in The Gray Sheet
Executive Summary
Medical Science Systems, Inc. says it will pursue corporate partnerships to commercialize a test for the identification of a genetic risk factor for coronary artery disease.
You may also be interested in...
Interleukin Restenosis Susceptibility Test Launch Expected In 2000
Interleukin Genetics is seeking a diagnostics partner to market and distribute its development-stage genetic screening test for determining a patient's susceptibility to restenosis following angioplasty and stenting.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.